Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin/clavulanate 625 mg plus amoxicillin 500 mg vs amoxicillin/clavulanate 1000 mg for acute bacterial rhinosinusitis
TCTR20200308001Phase 4Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin and clavulanic acid in Acute bacterial rhinosinusitis (ABRS) (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Jun 2017; status: completed.
02
Drugs
amoxicillinclavulanic acid
03
Conditions
Acute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on TCTR20200308001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200308001.